“Vortioxetine improves gastrointestinal motility and reduces intestinal inflammation in a cuprizone-induced multiple sclerosis model in mice”, Ann Med Res , vol. 33, no. 5, pp. 192–198, May 2026, Accessed: Jun. 01, 2026. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4909